Vindesine
![]() | |
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
methyl (5S,7S,9S)- 9-[(2β,3β,4β,5α,12β,19α)- 3-(aminocarbonyl)- 3,4-dihydroxy- 16-methoxy- 1-methyl- 6,7-didehydroaspidospermidin- 15-yl]- 5-ethyl- 5-hydroxy- 1,4,5,6,7,8,9,10-octahydro- 2H- 3,7-methanoazacycloundecino[5,4-b]indole- 9-carboxylate | |
| Clinical data | |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| Pregnancy category |
|
| Routes of administration | Intravenous |
| Legal status |
|
| Pharmacokinetic data | |
| Protein binding | 65-75% |
| Metabolism | Hepatic (CYP3A4-mediated) |
| Biological half-life | 24 hours |
| Excretion | Biliary and renal |
| Identifiers | |
| CAS Number |
59917-39-4 |
| ATC code | L01CA03 (WHO) |
| PubChem | CID 40839 |
| DrugBank |
DB00309 |
| ChemSpider |
37302 |
| UNII |
RSA8KO39WH |
| KEGG |
D01769 |
| ChEBI |
CHEBI:36373 |
| ChEMBL |
CHEMBL219146 |
| Chemical data | |
| Formula | C43H55N5O7 |
| Molar mass | 753.926 g/mol |
| |
| |
| (verify) | |
Vindesine is an anti-mitotic vinca alkaloid used in chemotherapy. It is used to treat many different types of cancer, including leukaemia, lymphoma, melanoma, breast cancer, and lung cancer.[1]
References
| ||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Sunday, April 03, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.

